148 related articles for article (PubMed ID: 9702289)
21. Affective disorder and epilepsy comorbidity: implications for development of treatments, preventions and diagnostic approaches.
Jobe PC
Clin EEG Neurosci; 2004 Jan; 35(1):53-68. PubMed ID: 15112464
[TBL] [Abstract][Full Text] [Related]
22. Recognizing and managing bipolar disorder in children.
Wozniak J
J Clin Psychiatry; 2005; 66 Suppl 1():18-23. PubMed ID: 15693748
[TBL] [Abstract][Full Text] [Related]
23. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder.
McElroy SL; Altshuler LL; Suppes T; Keck PE; Frye MA; Denicoff KD; Nolen WA; Kupka RW; Leverich GS; Rochussen JR; Rush AJ; Post RM
Am J Psychiatry; 2001 Mar; 158(3):420-6. PubMed ID: 11229983
[TBL] [Abstract][Full Text] [Related]
24. Bipolar disorders and quality of life: the impact of attention deficit/hyperactivity disorder and substance abuse in euthymic patients.
Sentissi O; Navarro JC; De Oliveira H; Gourion D; Bourdel MC; Baylé FJ; Olié JP; Poirier MF
Psychiatry Res; 2008 Oct; 161(1):36-42. PubMed ID: 18786727
[TBL] [Abstract][Full Text] [Related]
25. Toward a unitary perspective on the bipolar spectrum and substance abuse: opiate addiction as a paradigm.
Maremmani I; Perugi G; Pacini M; Akiskal HS
J Affect Disord; 2006 Jul; 93(1-3):1-12. PubMed ID: 16675028
[TBL] [Abstract][Full Text] [Related]
26. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
[TBL] [Abstract][Full Text] [Related]
27. Patterns of affective comorbidity in a clinical population of dually diagnosed adolescent substance abusers.
Bukstein OG; Glancy LJ; Kaminer Y
J Am Acad Child Adolesc Psychiatry; 1992 Nov; 31(6):1041-5. PubMed ID: 1429402
[TBL] [Abstract][Full Text] [Related]
28. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
Liraud F; Verdoux H
Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
[TBL] [Abstract][Full Text] [Related]
29. Pharmacotherapy of comorbid mood, anxiety, and substance use disorders.
Brady KT; Verduin ML
Subst Use Misuse; 2005; 40(13-14):2021-41, 2043-8. PubMed ID: 16282091
[TBL] [Abstract][Full Text] [Related]
30. Bipolar rapid cycling: focus on depression as its hallmark.
Calabrese JR; Shelton MD; Bowden CL; Rapport DJ; Suppes T; Shirley ER; Kimmel SE; Caban SJ
J Clin Psychiatry; 2001; 62 Suppl 14():34-41. PubMed ID: 11469674
[TBL] [Abstract][Full Text] [Related]
31. The longitudinal polymorphism of bipolar I disorders and its theoretical implications.
Marneros A; Roettig S; Roettig D; Tscharntke A; Brieger P
J Affect Disord; 2008 Apr; 107(1-3):117-26. PubMed ID: 17884177
[TBL] [Abstract][Full Text] [Related]
32. Psychopharmacological treatment of non-comorbid and comorbid pervasive developmental disorder and pediatric bipolar disorder.
Hamrin V; McDonnell MA; Moffett J; Durso S
Minerva Pediatr; 2008 Feb; 60(1):87-101. PubMed ID: 18277368
[TBL] [Abstract][Full Text] [Related]
33. Anxiety disorders in 318 bipolar patients: prevalence and impact on illness severity and response to mood stabilizer.
Henry C; Van den Bulke D; Bellivier F; Etain B; Rouillon F; Leboyer M
J Clin Psychiatry; 2003 Mar; 64(3):331-5. PubMed ID: 12716276
[TBL] [Abstract][Full Text] [Related]
34. Childhood-compared to adolescent-onset bipolar disorder has more statistically significant clinical correlates.
Holtzman JN; Miller S; Hooshmand F; Wang PW; Chang KD; Hill SJ; Rasgon NL; Ketter TA
J Affect Disord; 2015 Jul; 179():114-20. PubMed ID: 25863906
[TBL] [Abstract][Full Text] [Related]
35. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.
Lee JH; Dunner DL
Depress Anxiety; 2008; 25(2):91-7. PubMed ID: 17311265
[TBL] [Abstract][Full Text] [Related]
36. Comorbid substance use disorders among youth with bipolar disorder: opportunities for early identification and prevention.
Goldstein BI; Bukstein OG
J Clin Psychiatry; 2010 Mar; 71(3):348-58. PubMed ID: 19961811
[TBL] [Abstract][Full Text] [Related]
37. Attrition factors in clinical trials of comorbid bipolar and substance-related disorders.
Nomamiukor N; Brown ES
J Affect Disord; 2009 Jan; 112(1-3):284-8. PubMed ID: 18511129
[TBL] [Abstract][Full Text] [Related]
38. [Comparative study of substance dependence comorbidity in bipolar, schizophrenic and schizoaffective disorders].
Verdoux H; Mury M; Besançon G; Bourgeois M
Encephale; 1996; 22(2):95-101. PubMed ID: 8706627
[TBL] [Abstract][Full Text] [Related]
39. Suicide attempts in major affective disorder patients with comorbid substance use disorders.
Tondo L; Baldessarini RJ; Hennen J; Minnai GP; Salis P; Scamonatti L; Masia M; Ghiani C; Mannu P
J Clin Psychiatry; 1999; 60 Suppl 2():63-9; discussion 75-6, 113-6. PubMed ID: 10073390
[TBL] [Abstract][Full Text] [Related]
40. [Affective disorders and impulsivity].
Belzeaux R; Correard N; Mazzola-Pomietto P; Adida M; Cermolacce M; Azorin JM
Encephale; 2014 Dec; 40 Suppl 3():S27-32. PubMed ID: 25550236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
